Skip to main content
Clinical Trials/ISRCTN59485808
ISRCTN59485808Completed未知

2D vs. 3D laparoscopic anterior resection: a randomised controlled trial

Yeovil District Hospital NHS Foundation Trust0 sites88 target enrollmentStarted: December 16, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
88

Study Overview

Brief Summary

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30656453 results (added 13/03/2019) 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31567928/ Factors predicting operative difficulty (added 10/01/2023)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Patients diagnosed with adenocarcinoma of the rectum (<15cm from anal verge as measured by staging MRI )
  • 2. Scheduled to undergo elective laparoscopic TME/ partial mesorectal excision surgery with curative intent, with or without neo-adjuvant treatment and with or without defunctioning stoma formation
  • 3. Written informed patient consent

Exclusion Criteria

  • 1. History of inflammatory bowel disease
  • 2. Patients requiring abdomino-perineal excision or surgery without anastomosis
  • 3. Advanced tumours involving adjacent organs (TNM5 T4aNxMx)
  • 4. Surgery performed with palliative intent or under unplanned/emergency settings
  • 5. Previous treatment (radiotherapy/abdominopelvic surgery) for endometrial, ovarian, prostate, bladder (TURBT ok), anal or vaginal cancer
  • 6. Patient or surgeon refusal to enter study or accept randomisation result

Investigators

Sponsor
Yeovil District Hospital NHS Foundation Trust

Similar Trials

The role of 3D laparoscopic rectal... | Clinical Trial